14.05.2013
- John Lechleiter, the longtime chief executive of Eli Lilly, is recovering from successful surgery to repair a dilated aorta, the U.S. drugmaker said on Tuesday. "Dr. Lechleiter is...
03.05.2013
- Eli Lilly, the world's fourth-largest diabetes drugs maker, aims to have the widest range of anti diabetic drugs in order to win a larger slice in the growing market. The global...
01.05.2013
- Denmark's Novo Nordisk could see the U.S. launch of its biggest drug hope, a new long-acting insulin, delayed until 2018 while it conducts more tests to satisfy regulators, it said...
30.04.2013
- Zoetis, formerly the animal health subsidiary of U.S. pharmaceuticals giant Pfizer, posted a stronger-than-expected quarterly profit, driven by growth in sales of pet products in...
12.04.2013
- Drugmaker Eli Lilly plans to lay off about 1,000 domestic sales representatives, or 30% of its U.S. sales force, as it faces new generic competition for its top drugs, a person...
29.03.2013
- The United States is striving to find an appropriate balance in Asia-Pacific free trade talks between providing strong patent and data protections for U.S. drug manufacturers and...
18.03.2013
- Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers scented an opportunity and raced to develop new medicines...
14.02.2013
- President Barack Obama's decision to spotlight drug rebates as a way to save money on Medicare is likely to be opposed by the pharmaceutical industry, which could potentially lose...